ARCHIVES

Brawley: CMS Got it Right in Lung Cancer Screening Decision

This article is from The Cancer Letter archive.

Vol. 40 No. 43 | November 14, 2014

Download PDF Visit The Full Archive

Related Articles

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

March 1, 2002

Kennedy, Waxman Disagree On Authorization Issue; Legislation For NIH, NCI This Congress Threatened

September 26, 1980

Cancer Care Uneven, IOM’s National Cancer Policy Board Concludes

April 9, 1999

NCI Communications Director Sieber To Retire; Science Planner Waldrop Also To Leave NCI.

September 14, 2001

Drug Development Effort Criticized

April 18, 1975

FDA Approves Generic Version Of Capecitabine for Metastatic Colorectal and Breast Cancer

September 27, 2013